Age-Related Macular Degeneration (Amd) Market Report

China Age-Related Macular Degeneration (Amd) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 23, 2023
  • PAGES：192
  • REPORT CODE：GMM1751431
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Age-Related Macular Degeneration (Amd) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis Ag

    • F Hoffmann-La Roche Ltd

    • Glaxosmithkline Plc

    • Bayer Ag

    • Stemcells Inc

    • Regeneron Pharmaceutical, Inc

    • Acucela

    • Ophthotech Corporation

    • Neurotech Pharmaceuticals, Inc

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Age-Related Macular Degeneration (Amd) Market Overview 2018-2029

    • 1.1 China Age-Related Macular Degeneration (Amd) Industry Development Overview

    • 1.2 China Age-Related Macular Degeneration (Amd) Industry Development History

    • 1.3 China Age-Related Macular Degeneration (Amd) Industry Market Size (2018-2029)

    • 1.4 China Age-Related Macular Degeneration (Amd) Market Analysis by Type from Production Side

      • 1.4.1 China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Age-Related Macular Degeneration (Amd) Market Analysis by Application from Consumption End

      • 1.5.1 China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Age-Related Macular Degeneration (Amd) Market Analysis by Region

      • 1.6.1 North China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Age-Related Macular Degeneration (Amd) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Age-Related Macular Degeneration (Amd) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Age-Related Macular Degeneration (Amd) Market Status and Competition Analysis in 2023

      • 2.2.3 China Age-Related Macular Degeneration (Amd) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Age-Related Macular Degeneration (Amd) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Age-Related Macular Degeneration (Amd) Industry Development

    Chapter 3 Age-Related Macular Degeneration (Amd)Industry Chain Analysis

    • 3.1 Age-Related Macular Degeneration (Amd) Industry Chain

    • 3.2 Age-Related Macular Degeneration (Amd) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Age-Related Macular Degeneration (Amd) Market

    • 3.3 Age-Related Macular Degeneration (Amd) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Age-Related Macular Degeneration (Amd) Market

    Chapter 4 China Age-Related Macular Degeneration (Amd) Market, by Type

    • 4.1 China Age-Related Macular Degeneration (Amd) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Age-Related Macular Degeneration (Amd) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate, by Type

      • 4.5.1 China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 1

      • 4.5.2 China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 2

      • 4.5.3 China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 3

    Chapter 5 China Age-Related Macular Degeneration (Amd) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Age-Related Macular Degeneration (Amd) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate, by Application

      • 5.5.1 China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 1

      • 5.5.2 China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 2

      • 5.5.3 China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 3

    Chapter 6 China Age-Related Macular Degeneration (Amd) Market, by Region

    • 6.1 China Age-Related Macular Degeneration (Amd) Production Volume and Production Value, by Region

    • 6.2 China Age-Related Macular Degeneration (Amd) Sales Volume and Sales Value, by Region

    Chapter 7 North China Age-Related Macular Degeneration (Amd) Market Analysis

    • 7.1 North China Age-Related Macular Degeneration (Amd) Market, by Type

    • 7.2 North China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 8 Central China Age-Related Macular Degeneration (Amd) Market Analysis

    • 8.1 Central China Age-Related Macular Degeneration (Amd) Market, by Type

    • 8.2 Central China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 9 South China Age-Related Macular Degeneration (Amd) Market Analysis

    • 9.1 South China Age-Related Macular Degeneration (Amd) Market, by Type

    • 9.2 South China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 10 East China Age-Related Macular Degeneration (Amd) Market Analysis

    • 10.1 East China Age-Related Macular Degeneration (Amd) Market, by Type

    • 10.2 East China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 11 Northeast China Age-Related Macular Degeneration (Amd) Market Analysis

    • 11.1 Northeast China Age-Related Macular Degeneration (Amd) Market, by Type

    • 11.2 Northeast China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 12 Southwest China Age-Related Macular Degeneration (Amd) Market Analysis

    • 12.1 Southwest China Age-Related Macular Degeneration (Amd) Market, by Type

    • 12.2 Southwest China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 13 Northwest China Age-Related Macular Degeneration (Amd) Market Analysis

    • 13.1 Northwest China Age-Related Macular Degeneration (Amd) Market, by Type

    • 13.2 Northwest China Age-Related Macular Degeneration (Amd) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis Ag

        • 14.1.1 Novartis Ag Company Profile

        • 14.1.2 Novartis Ag Age-Related Macular Degeneration (Amd) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 F Hoffmann-La Roche Ltd

        • 14.2.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.2.2 F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (Amd) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Glaxosmithkline Plc

        • 14.3.1 Glaxosmithkline Plc Company Profile

        • 14.3.2 Glaxosmithkline Plc Age-Related Macular Degeneration (Amd) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer Ag

        • 14.4.1 Bayer Ag Company Profile

        • 14.4.2 Bayer Ag Age-Related Macular Degeneration (Amd) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Stemcells Inc

        • 14.5.1 Stemcells Inc Company Profile

        • 14.5.2 Stemcells Inc Age-Related Macular Degeneration (Amd) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Regeneron Pharmaceutical, Inc

        • 14.6.1 Regeneron Pharmaceutical, Inc Company Profile

        • 14.6.2 Regeneron Pharmaceutical, Inc Age-Related Macular Degeneration (Amd) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Acucela

        • 14.7.1 Acucela Company Profile

        • 14.7.2 Acucela Age-Related Macular Degeneration (Amd) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Ophthotech Corporation

        • 14.8.1 Ophthotech Corporation Company Profile

        • 14.8.2 Ophthotech Corporation Age-Related Macular Degeneration (Amd) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Neurotech Pharmaceuticals, Inc

        • 14.9.1 Neurotech Pharmaceuticals, Inc Company Profile

        • 14.9.2 Neurotech Pharmaceuticals, Inc Age-Related Macular Degeneration (Amd) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Age-Related Macular Degeneration (Amd) Industry Research Conclusions

    • 15.2 Age-Related Macular Degeneration (Amd) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Age-Related Macular Degeneration (Amd) Industry Market Size (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Age-Related Macular Degeneration (Amd) Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure Central China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure South China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure East China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate from 2018-2029

    • Figure Age-Related Macular Degeneration (Amd) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Age-Related Macular Degeneration (Amd) Market Share by Type in 2018

    • Figure China Age-Related Macular Degeneration (Amd) Market Share by Type in 2023

    • Figure China Age-Related Macular Degeneration (Amd) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Market Share by Application in 2018

    • Figure China Age-Related Macular Degeneration (Amd) Market Share by Application in 2023

    • Figure China Age-Related Macular Degeneration (Amd) Total Market Size and Growth Rate from Consumption End

    • Figure China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Production Volume by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Production Volume Share by Region (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Production Volume Share by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Production Value by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Production Value Share by Region (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Production Value Share by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Sales Volume by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Sales Volume Share by Region (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Sales Volume Share by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Sales Value by Region (2018-2023)

    • Table China Age-Related Macular Degeneration (Amd) Sales Value Share by Region (2018-2023)

    • Figure China Age-Related Macular Degeneration (Amd) Sales Value Share by Region (2018-2023)

    • Table North China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table North China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure North China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table North China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table North China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure North China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table Central China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table Central China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure Central China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table Central China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table Central China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure Central China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table South China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table South China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure South China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table South China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table South China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure South China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table East China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table East China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure East China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table East China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table East China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure East China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table Northeast China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table Northeast China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table Northeast China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table Southwest China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table Southwest China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table Southwest China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Age-Related Macular Degeneration (Amd) Production Volume by Type (2018-2023)

    • Table Northwest China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Age-Related Macular Degeneration (Amd) Production Volume Share by Type (2018-2023)

    • Table Northwest China Age-Related Macular Degeneration (Amd) Sales Volume by Application (2018-2023)

    • Table Northwest China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Age-Related Macular Degeneration (Amd) Sales Volume Share by Application (2018-2023)

    • Table Novartis Ag Company Profile

    • Table Novartis Ag Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Glaxosmithkline Plc Company Profile

    • Table Glaxosmithkline Plc Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Bayer Ag Company Profile

    • Table Bayer Ag Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Stemcells Inc Company Profile

    • Table Stemcells Inc Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Regeneron Pharmaceutical, Inc Company Profile

    • Table Regeneron Pharmaceutical, Inc Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Acucela Company Profile

    • Table Acucela Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Ophthotech Corporation Company Profile

    • Table Ophthotech Corporation Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)

    • Table Neurotech Pharmaceuticals, Inc Company Profile

    • Table Neurotech Pharmaceuticals, Inc Age-Related Macular Degeneration (Amd) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US